Cadrenal Therapeutics, Inc. (CVKD) vs HCW Biologics Inc. (HCWB)

Cadrenal Therapeutics, Inc. and HCW Biologics Inc. are both Biotechnology companies. Cadrenal Therapeutics, Inc. and HCW Biologics Inc. are of similar size ($4.3M and $4.2M). Cadrenal Therapeutics, Inc. has the higher net margin (0.00% vs −329.4%) and the lower return on invested capital (−427.5% vs −36.2%). Across the 14 metrics below, Cadrenal Therapeutics, Inc. leads on 8 and HCW Biologics Inc. on 6.

Valuation

Metric CVKD HCWB Biotechnology median
P/E n/m n/m 7.88
P/S n/m 0.38 11.47
P/B 0.82 0.35 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 1.30 10.73
Earnings yield (426.09%) (1,429.91%) (28.84%)
Free cash flow yield (303.35%) (483.74%) (23.03%)

Profitability

Metric CVKD HCWB Biotechnology median
Gross margin 0.00% 95.91% 65.16%
Operating margin 0.00% (114.02%) 0.00%
Net margin 0.00% (329.38%) 0.00%
Free cash flow margin 0.00% (180.57%) 0.00%
Return on equity (275.16%) (600.32%) (57.72%)
Return on assets (199.59%) (79.52%) (49.22%)
Return on invested capital (427.54%) (36.15%) 0.00%

Growth

Metric CVKD HCWB Biotechnology median
Revenue growth (TTM) — 706.96% 5.64%
EPS growth (last fiscal year) 23.94% 65.49% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CVKD HCWB Biotechnology median
Debt to equity 0.00 0.88 0.00
Current ratio 3.73 0.06 4.73
Net debt to EBITDA 0.30 (0.40) 0.96

Dividend

Metric CVKD HCWB Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric CVKD HCWB Biotechnology median
Market cap 4.29m 4.18m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack